This paper compared detection of SARS-CoV-2, the virus that causes the novel 2019 coronavirus disease (COVID, COVID-19, COVID19), in matched self-collected anterior nasal swab and saliva specimens with healthcare worker–collected nasopharyngeal swab specimens.
Self-Collected Anterior Nasal and Saliva Specimens versus Health Care Worker-Collected Nasopharyngeal Swabs for the Molecular Detection of SARS-CoV-2.
Hanson KE, Barker AP, Hillyard DR, Gilmore N, Barrett JW, Orlandi RR, Shakir SM
Purpose
Conclusion
SARS-CoV-2 diagnostic concordance was high between healthcare worker-collected nasopharyngeal swab specimens and self-collected nasal swab and saliva specimens. Positivity rates were higher for nasopharyngeal swabs and saliva specimens than for nasal swab specimens, but the differences were not statistically significant.
Studies (1)
Purpose
This study compared detection of SARS-CoV-2 in matched self-collected anterior nasal swab and saliva specimens with healthcare worker–collected nasopharyngeal swab specimens. Swab specimens were collected by healthcare-workers (details not provided) from 354 patients (47% female, 53% male) with symptoms suggestive of SARS-CoV-2 infection which included one or more of the following: fever, cough, shortness of breath, sore throat, malaise, chills, and/or a decreased sense of smell or taste. Participants were instructed to swab both nostrils with flocked swabs and then pool saliva in their mouth without coughing and repeatedly spit a minimum of 1 mL saliva into a sterile, empty tube. A healthcare worker then collected a nasopharyngeal specimen using a foam swab. All swabs were placed in tubes containing sterile phosphate-buffered saline solution, transported at 4°C to the lab with the saliva specimens, and stored refrigerated until processed ≤5 days. All specimens were analyzed using an Hologic Aptima SARS-CoV-2 transcription-mediated amplification assay.
Summary of Findings
SARS-Cov-2 diagnostic concordance was high between healthcare worker-collected nasopharyngeal swab specimens and self-collected nasal swab and saliva specimens (κ=0.889 and κ=0.912, respectively). The percent positive agreement was 86.3% between nasopharyngeal swab and nasal swab specimens and 93.8% between nasopharyngeal swab and saliva specimens and the percent negative agreement was 99.6% for nasopharyngeal swab versus nasal swab specimens and 97.8% for nasopharyngeal swabs versus saliva specimens. Overall, 66 (18.6%) patients had SARS-CoV-2 detected in all three specimen types, 13 (3.7%) in two specimen types, and seven (2.0%) in one specimen type. Of the 13 cases in which SARS-CoV-2 was detected in two of the three specimens, nine (69.2%) had SARS-CoV-2 detected in nasopharyngeal swab and saliva specimens, three (23%) had SARS-CoV-2 detected in nasopharyngeal swab and nasal swab specimens, and a single patient (7.7%) had SARS-CoV-2 detected in saliva and nasal swab specimen. Of the seven cases in which SARS-CoV-2 was detected a single specimen, two (28.6%) were detected in nasopharyngeal swab only, five (71.4%) in saliva only, and none were detected solely in nasal swab specimens. Positivity rates were higher for nasopharyngeal swab (22.5%; 80/354) and saliva specimens (22.9%; 81/354) than for nasal swab specimens (19.7%; 70/354) but this did not reach statistical significance.
Biospecimens
CellNasal cavityCellNasopharynxFluidSalivaPreservation Types
None (Fresh)Diagnoses
Pneumonia/Respiratory InfectionPlatforms
RNARNA amplificationPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Biospecimen location Nasal cavityNasopharynxSalivaBiospecimen Acquisition Method of cell acquisition Healthcare worker–collected swabsSelf-collected nasal swabsSelf-collected saliva